News for Innoviva, Inc. (INVA)

Innoviva (INVA) has recently caught the attention of HC Wainwright & Co., as the investment firm has initiated coverage of the stock with a "Buy" rating. This d

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

H.C. Wainwright has started coverage on Innoviva (INVA), giving it a

Cantor Fitzgerald has started coverage on Innoviva (INVA) with an Overweight rating, setting a price target of $26. This new rating indicates Cantor Fitzgerald'

PR NewswireDUBLIN, July 10, 2025 ”“ Selection Follows Robust Succession Process Led by the Board ”“”“ Bruce Cozadd to Retire as CEO and Remain Chairpers

Key Points: Innoviva's FDA review for zoliflodacin marks a significant step in treating gonorrhea. Wall Street analysts predict a notable upside for Inno

Summary Innoviva Inc (INVA), through its subsidiary Innoviva Specialty Therapeutics, has announced that the U.S. Food and Drug Administration (FDA) has accepted

Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), in collaboration with the Global Antibiotic Research & Development Partne

Discover how Innoviva's diversified model drives growth through GSK royalties and specialty therapeutics.

Summary Innoviva Inc (INVA), a diversified holding company with a focus on royalties and healthcare investments, announced its participation in two significant

**media[631030]**

We recently published a list of 10 Stocks with Insanely High PE Ratios Insiders Are Selling. In this article, we are going to take a look at where Innoviva, Inc. (NASDAQ:INVA) stands against other stocks with insanely high PE ratios insiders are selling. The U.S. stock market has turned into a theater of extremes right […]

Transaction Overview On March 31, 2025, BlackRock, Inc. (Trades, Portfolio) executed a significant transaction involving Innoviva Inc (INVA), a company operatin

U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Tuesday. Shares of Excelerate Energy, Inc. EE fell sharply in ...

On March 13, 2025, Sarissa Capital Management LP (Trades, Portfolio) executed a significant transaction involving Innoviva Inc. The firm reduced its holdings by

PR NewswireLOS ANGELES, March 12, 2025 Proceeds to be used to continue to advance development of Armata's phage product candidates LOS ANGELES, March 12, 2

Summary Innoviva Inc (INVA), a diversified holding company with a focus on royalties and healthcare investments, announced that its CEO, Pavel Raifeld, will par

Robust royalty portfolio with strong partnerships and innovative healthcare assets.Expansion into critical care and infectious disease markets through strategi

On February 26, 2025, Innoviva Inc (INVA) released its 8-K filing, detailing its financial results for the fourth quarter and full year 2024. Innoviva Inc, a di